Browse 13 Pharmaceutical companies funded by IMM Investment. See funding amounts, founder contacts, and investment details.
Mito Immune Therapeutics is a drug research and development biotech company.
Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.
Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Cellemedy is a biotechnology company that develops next-generation therapeutic proteins to replace conventional antibody treatments.
Zymedi is a pharmaceutical company that develops drugs for life-threatening diseases.
Medb Korea is a medical consumer, hospital, and pharmacy-focused online medical care and prescription drug delivery platform.
UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.
Kobiolabs is a microbiome-based venture
Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics.
Teoul is a digital healthcare management company that offers solutions for pharmacists to provide professional and easy medication guidance.
SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.
J2H Biotech is a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases.
View all companies funded by IMM Investment across every industry and funding stage.
View Full IMM Investment Portfolio